Literature DB >> 7892192

Activation of a neurofilament kinase, a tau kinase, and a tau phosphatase by decreased ATP levels in nerve growth factor-differentiated PC-12 cells.

M L Bush1, J S Miyashiro, V M Ingram.   

Abstract

Brain pathology in Alzheimer disease and in aged controls shows hyperphosphorylation of tau and of neurofilament proteins. Roder and Ingram [Roder, H.M. & Ingram, V.M. (1991) J. Neurosci. 11, 3325-3343 and Roder, H.M., Eden, P.A. & Ingram, V.M. (1993) Biochem. Biophys. Res. Commun. 193, 639-647] previously reported that the brain protein kinase PK40erk can hyperphosphorylate both tau and neurofilaments and interestingly, is strongly inhibited by ATP uncomplexed with Mg2+. We now report that the mitochondrial uncoupler carbonyl cyanide p-trifluoro-methoxyphenylhydrazone decreases ATP levels in rat pheochromacytoma (PC-12) cells differentiated with nerve growth factor and activates a neurofilament kinase, a tau kinase, and, unexpectedly, a tau phosphatase--either PP1 or PP2A. Such aberrant modulation of protein phosphorylation patterns could be the common biochemical basis for senile dementia and for Alzheimer disease and could explain the late-onset etiology of both conditions.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7892192      PMCID: PMC42382          DOI: 10.1073/pnas.92.6.1861

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  30 in total

1.  A new class of uncoupling agents--carbonyl cyanide phenylhydrazones.

Authors:  P G HEYTLER; W W PRICHARD
Journal:  Biochem Biophys Res Commun       Date:  1962-05-04       Impact factor: 3.575

2.  Two novel kinases phosphorylate tau and the KSP site of heavy neurofilament subunits in high stoichiometric ratios.

Authors:  H M Roder; V M Ingram
Journal:  J Neurosci       Date:  1991-11       Impact factor: 6.167

3.  Abnormalities of glucose metabolism in Alzheimer's disease.

Authors:  S Hoyer
Journal:  Ann N Y Acad Sci       Date:  1991       Impact factor: 5.691

4.  Tau protein kinase I converts normal tau protein into A68-like component of paired helical filaments.

Authors:  K Ishiguro; M Takamatsu; K Tomizawa; A Omori; M Takahashi; M Arioka; T Uchida; K Imahori
Journal:  J Biol Chem       Date:  1992-05-25       Impact factor: 5.157

5.  Tau proteins of Alzheimer paired helical filaments: abnormal phosphorylation of all six brain isoforms.

Authors:  M Goedert; M G Spillantini; N J Cairns; R A Crowther
Journal:  Neuron       Date:  1992-01       Impact factor: 17.173

6.  Phosphorylation-dependent epitopes of neurofilament antibodies on tau protein and relationship with Alzheimer tau.

Authors:  B Lichtenberg-Kraag; E M Mandelkow; J Biernat; B Steiner; C Schröter; N Gustke; H E Meyer; E Mandelkow
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-15       Impact factor: 11.205

7.  A68: a major subunit of paired helical filaments and derivatized forms of normal Tau.

Authors:  V M Lee; B J Balin; L Otvos; J Q Trojanowski
Journal:  Science       Date:  1991-02-08       Impact factor: 47.728

8.  FCCP releases Ca2+ from a non-mitochondrial store in an identified Helisoma neuron.

Authors:  J R Jensen; V Rehder
Journal:  Brain Res       Date:  1991-06-14       Impact factor: 3.252

9.  Mitogen activated protein (MAP) kinase transforms tau protein into an Alzheimer-like state.

Authors:  G Drewes; B Lichtenberg-Kraag; F Döring; E M Mandelkow; J Biernat; J Goris; M Dorée; E Mandelkow
Journal:  EMBO J       Date:  1992-06       Impact factor: 11.598

10.  High molecular weight tau: preferential localization in the peripheral nervous system.

Authors:  I S Georgieff; R K Liem; W Mellado; J Nunez; M L Shelanski
Journal:  J Cell Sci       Date:  1991-09       Impact factor: 5.285

View more
  4 in total

1.  Compromised mitochondrial function leads to increased cytosolic calcium and to activation of MAP kinases.

Authors:  Y Luo; J D Bond; V M Ingram
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-02       Impact factor: 11.205

2.  Effect of adrenalectomy and corticosterone substitution on glucose and glycogen metabolism in rat brain.

Authors:  K Plaschke; D Müller; S Hoyer
Journal:  J Neural Transm (Vienna)       Date:  1996       Impact factor: 3.575

3.  Neuroprotection of a sesamin derivative, 1, 2-bis [(3-methoxyphenyl) methyl] ethane-1, 2-dicaroxylic acid (MMEDA) against ischemic and hypoxic neuronal injury.

Authors:  Chang-Tsen Hung; Li-Dian Chen; Chien-Wei Hou
Journal:  Iran J Basic Med Sci       Date:  2017-12       Impact factor: 2.699

4.  Protective effect of a sesamin derivative, 3-bis (3-methoxybenzyl) butane-1, 4-diol on ischemic and hypoxic neuronal injury.

Authors:  Chien-Wei Hou; Yi-Ling Chen; Shih-Hsien Chuang; Jen-Shu Wang; Kee-Ching Jeng
Journal:  J Biomed Sci       Date:  2014-02-18       Impact factor: 8.410

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.